Kymera Therapeutics Cash Flow Statement (2019-2026) | KYMR

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-24.76M-28.71M-34.05M-36.97M-40.85M-44.92M-38.69M-45.38M-43.43M-57.55M-19.36M-57.90M-50.99M-72.18M-80.81M-74.50M-84.67M-92.62M-97.99M-84.22M
Depreciation and Depletion (Quarter)
0.60M700.002.40M0.70M0.70M0.80M0.80M0.90M0.90M0.90M0.90M1.50M1.90M2.00M2.00M1.60M1.70M2.10M2.90M1.60M
Share-based Compensation (Quarter)
5.73M7.40M-15.99M7.87M9.62M9.08M8.91M9.38M11.18M11.65M10.90M11.97M14.34M14.90M13.80M14.23M15.41M15.80M14.45M16.01M
Gains from Sales and Divestitures (Quarter)
0.04M0.05M0.08M0.01M0.03M0.04M0.04M0.03M0.03M0.04M0.04M0.08M0.16M0.17M0.17M0.15M0.22M0.28M0.28M0.19M
Gains from Investment Securities (Quarter)
18.70M2.40M2.80M1.00M48.83M0.26M0.39M1.80M10.40M-19.17M2.10M5.30M-8.84M0.07M
Asset Writedowns and Impairment (Quarter)
4.92M-0.03M3.85M0.00M
Non-cash Items (Quarter)
197.00M1.73M246.93M131.55M75.20M3.21M55.93M3.71M4.21M64.90M49.62M5.09M57.03M80.70M97.72M6.56M84.50M73.50M5.95M410.60M
Cash from Operations (Quarter)
-30.51M-37.26M-38.35M-40.30M-38.98M-34.27M-39.54M-43.97M-35.26M-31.65M8.04M-39.59M-42.94M-50.19M-61.78M-79.15M-59.88M-27.11M-66.75M-88.84M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
1.23M1.66M1.64M1.18M0.68M-0.06M-0.91M-1.33M-1.42M-1.22M-1.27M-3.07M-4.02M-3.62M-3.27M-2.52M-2.12M-2.19M-2.04M-2.73M
Depreciation & Amortization (CF) (Quarter)
0.55M0.67M0.69M0.69M0.70M0.77M0.82M0.88M0.90M0.90M0.89M1.46M1.94M1.99M1.99M2.05M2.08M2.15M2.03M2.02M
Change in Working Capital
Change in Account Payables (Quarter)
-0.14M-2.92M-1.03M-1.44M-0.41M4.17M-2.07M2.22M-2.73M1.02M1.53M0.07M0.03M0.09M-0.51M3.92M-4.13M-0.27M-1.49M8.82M
Change in Accured Expenses (Quarter)
3.86M4.71M3.80M-2.28M0.56M3.40M2.84M-10.04M3.79M2.64M6.79M-15.39M7.80M2.75M9.02M-11.69M4.75M0.66M13.66M-7.21M
Other Working Capital Changes (Quarter)
-1.40M1.65M-2.08M-8.36M-9.14M17.84M-38.11M-0.36M4.35M0.38M-2.42M-8.26M-23.95M37.96M-6.06M-2.78M29.20M-2.76M-21.30M-1.36M
Investing Activities
Capital Expenditures (Quarter)
0.63M0.31M0.50M0.48M0.73M1.25M0.37M4.01M10.77M8.08M11.62M7.40M4.69M-0.19M0.94M0.47M0.69M0.18M0.11M0.43M
Change in Acquisitions & Divestments (Quarter)
91.50M109.29M96.88M106.46M147.25M117.67M97.94M90.43M99.25M97.76M76.08M99.50M124.49M138.07M147.93M132.74M118.97M132.44M103.87M133.86M
Cash from Investing Activities (Quarter)
60.72M-136.86M-68.02M25.86M81.80M-37.48M-49.67M24.58M35.84M60.51M18.95M-330.61M15.64M-157.68M68.57M48.62M60.02M-235.30M-394.40M-142.84M
Financing Activities
Other financing activities (Quarter)
0.19M0.35M0.16M0.26M0.27M0.29M0.30M0.33M0.33M0.34M-0.93M0.29M0.35M0.64M0.29M0.28M0.38M0.42M0.42M0.42M
Cash from Financing Activities (Quarter)
1.59M246.04M2.05M0.18M0.36M150.50M1.95M1.16M1.30M-0.21M1.93M353.76M1.41M250.92M2.77M0.26M245.73M39.51M705.22M18.77M
Additional items
Change in Cash (Quarter)
31.80M71.92M-104.32M-14.25M43.18M78.75M-87.25M-18.23M1.89M28.66M28.93M-16.44M-25.88M43.05M9.55M-30.28M245.86M-222.90M244.07M-212.91M
Free Cash Flow (Quarter)
-31.14M-37.57M-38.85M-40.78M-39.72M-35.52M-39.91M-47.98M-46.02M-39.73M-3.58M-46.99M-47.62M-50.00M-62.72M-79.62M-60.58M-27.29M-66.85M-89.27M
Net Cash Flow (Quarter)
31.80M71.92M-104.32M-14.25M43.18M78.75M-87.25M-18.23M1.89M28.66M28.93M-16.44M-25.88M43.05M9.55M-30.28M245.86M-222.90M244.07M-212.91M